Old Website Link
csir-logo

सी.एस.आई.आर - केन्द्रीय औषधि अनुसंधान संस्थान, लखनऊ
CSIR-Central Drug Research Institute, Lucknow

cdri-logo
    • Home
    • Profile
    • Mission & Vision
    • Organisation Structure
  • People
    • Director
    • Scientist
      • By Division
      • By Research Areas
    • Administration
    • Technical & Support Staff
  • Research
    • Cancer
    • Metabolic Disorders
    • Microbial Infections
    • Muscoskeletal Health and Disorders
    • Neurological Disorders
    • Parasitic Infections
    • Reproductive Health
    • Virus Research & Therapeutics
  • Pipeline
    • Small Molecules
    • Phytopharmaceuticals
    • Novel Formulations
    • Patents
      • Product Patents
      • Process Patents
  • Business
    • BD & IP Unit
    • Partnering
    • CSR
  • Services
    • Biological screening
    • Toxicology
    • Formulation Development & Pharmacokinetics
    • CRTDH
    • X-ray Crystallography
    • SAIF
    • Laboratory Animals Centre
  • Academics
    • Academic Affairs Unit
    • Ph.D.
    • Project Associates/Post-doc
    • Internship/Trainee
    • Skill Development
    • International Scholar
    • Outreach Program
    • Campus Life
    • Training for Scholarship Awardees
    • Advance Training Programme
Alternate Text

Formulation Development & Pharmacokinetics

CSIR-CDRI provides a comprehensive suite of physicochemical analysis solutions and expertise essential for advancing drug formulation development. These services ensure that each formulation is optimized for bioavailability and processing requirements, including detailed characterization of drug properties, rigorous solubility and stability testing, and thorough compatibility studies with excipients and delivery systems.

  • 1. In vitro ADME
    • a) Solubility
    • b) Simulated intestinal and gastric fluid with and without enzymes
    • c) Permeability
    • d) Plasma stability and plasma protein binding
    • e) Blood to plasma ratio
    • f) Metabolic stability (microsomal/S9)

  • 2. Method Development
    • a) Bioanalytical method development
    • b) Method validation as per FDA guidelines

  • 3. Single dose PK studies in rodents
    • a) Oral
    • b) Intravenous

  • 4. Metabolic reaction phenotyping
    • a) Preclinical species
    • b) Human (microsomes and recombinant enzymes)
  • 5. Tissue distribution
  • 6. Excretion (urine and feces)
  • 7. PK in non-human primates (samples provided by Toxicology Div.)
  • 8. Dose proportionality study ( at three dose X, X/2 and 2X)

Contact:

Dr. Kaushik Bhattacharjee

Coordinator, Biological Screening

+91-522-2772486

bio-screen[AT]cdri.res.in

  • How to Reach
  • Ethics in Research
  • Integrity Pledge
  • CDRI Publications
  • CTDDR-2025
  • Honours and Awards
  • SAIF- CDRI
  • Annual Reports
  • CDRI Newsletter
  • GST Certificate
  • Staff List
  • Procurement Projection
  • Rate Contract

Contact Us

CSIR-Central Drug Research Institute, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow-226031

: +91-522 2772450

: director_office[AT]cdri.res.in

: https://www.cdri.res.in

For Department Specifc Query
Copyright © 2024 CSIR-CDRI,Lucknow
Faq

Accessibility options by UX4G

Text To Speech
Bigger Text
Small Text
Line Height
Highlight Links
Text Spacing
Dyslexia Friendly
Hide Images
Cursor
Light-Dark
Invert Colors
Reset All Settings
Accessibility OptionsAccessibility Options